Big Molecule Watch
- Bio-Thera Solutions Expands Partnership with SteinCares to Market Two Biosimilars in LATAM December 19, 2024 Alison Siedor
- FDA Approves New Biologic Cancer Treatments December 16, 2024 Emma Murray
- FDA Designates Intellia’s Nexiguran Ziclumeran (nex-z) as a Regenerative Medicine Advanced Therapy December 16, 2024 Yoko Bian
- Intas Expands Cancer Therapy Biosimilar Portfolio December 16, 2024 Tara Thigpen
- Recent Biologics Deals December 13, 2024 Beth Ashbridge|Aru Goyal
- Now Available! Updated Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., 2024-2025 December 9, 2024 Sarah Clarke
- Biocon Announces FDA Approval of Ustekinumab Biosimilar December 7, 2024 Stephanie Dusaban Gonzales
- Update on Pending Denosumab BPCIA Litigations December 4, 2024 Harrison Gunn
- European Commission Approves Samsung Bioepis and Biogen’s Aflibercept Biosimilar November 27, 2024 Daniel Farraye
- FDA approves CAR-T Cell Therapy for Refractory B-cell Precursor Acute Lymphoblastic Leukemia November 19, 2024 Sam Herron
BioPharma Reporter
- Roche and Prothena’s Parkinson’s antibody treatment fails at phase 2 December 19, 2024
- FDA approves first mesenchymal stromal cell therapy December 19, 2024
- Teva and Sanofi’s IBD drug hits Phase 2 targets December 17, 2024
- Orexo and Abera collaborate to develop nasal powder vaccines December 17, 2024
- nChroma Bio formed by merging genetic medicine companies December 12, 2024
- SpliceBio gets FDA green light to start Phase 1/2 trial for inherited eye disease gene therapy December 12, 2024
- Eli Lilly invests $3bn in injectable drug manufacturing facility December 10, 2024
- Relation and GSK join forces to advance fibrotic diseases and osteoarthritis therapies December 10, 2024
- GSK and Muna Therapeutics partner to develop new treatments for Alzheimer’s December 10, 2024
- Cell and gene therapy access model launches in US December 5, 2024